153 related articles for article (PubMed ID: 31388197)
1. Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.
Santos TD; Jammal MP; Silveira TP; Murta EFC; Nomelini RS
Pathologica; 2019 Jun; 111(2):62-66. PubMed ID: 31388197
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.
Polat M; Senol T; Ozkaya E; Ogurlu Pakay G; Cikman MS; Konukcu B; Ozten MA; Karateke A
Clin Transl Oncol; 2016 May; 18(5):457-63. PubMed ID: 26289552
[TBL] [Abstract][Full Text] [Related]
3. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
[TBL] [Abstract][Full Text] [Related]
4. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.
Kim KH; Choi KU; Kim A; Lee SJ; Lee JH; Suh DS; Kwon BS; Hwang C
J Ovarian Res; 2019 Jun; 12(1):56. PubMed ID: 31208449
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
[TBL] [Abstract][Full Text] [Related]
8. Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer.
Martins Filho A; Jammal MP; Côbo Ede C; Silveira TP; Adad SJ; Murta EF; Nomelini RS
Immunol Lett; 2014; 158(1-2):195-9. PubMed ID: 24447864
[TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-to-lymphocyte ratio predicts 30 day postoperative morbidity and survival after primary surgery for ovarian cancer.
Nguyen JMV; Ferguson SE; Bernardini MQ; May T; Laframboise S; Hogen L; Bouchard-Fortier G
Int J Gynecol Cancer; 2020 Sep; 30(9):1378-1383. PubMed ID: 32788264
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract][Full Text] [Related]
11. The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer.
Winarno GNA; Pasaribu M; Susanto H; Nisa AS; Harsono AB; Yuseran H; Suardi D; Trianasari N
Asian Pac J Cancer Prev; 2021 May; 22(5):1561-1566. PubMed ID: 34048186
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy.
Henriksen JR; Nederby L; Donskov F; Waldstrøm M; Adimi P; Jakobsen A; Steffensen KD
J Ovarian Res; 2020 May; 13(1):59. PubMed ID: 32414391
[TBL] [Abstract][Full Text] [Related]
13. Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.
Thavaramara T; Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
J Med Assoc Thai; 2011 Jul; 94(7):871-7. PubMed ID: 21774296
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.
Salman L; Sabah G; Jakobson-Setton A; Raban O; Yeoshoua E; Eitan R
Int J Gynaecol Obstet; 2020 Jan; 148(1):102-106. PubMed ID: 31571212
[TBL] [Abstract][Full Text] [Related]
15. Comparison of neutrophil/lymphocyte and platelet/ lymphocyte ratios for predicting malignant potential of suspicious ovarian masses in gynecology practice.
Topcu HO; Guzel AI; Ozer I; Kokanali MK; Gokturk U; Muftuoglu KH; Doganay M
Asian Pac J Cancer Prev; 2014; 15(15):6239-41. PubMed ID: 25124604
[TBL] [Abstract][Full Text] [Related]
16. TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer.
Nomelini RS; Borges Júnior LE; de Lima CA; Chiovato AFC; Micheli DC; Tavares-Murta BM; Murta EFC
Clin Exp Med; 2018 Nov; 18(4):547-554. PubMed ID: 29802567
[TBL] [Abstract][Full Text] [Related]
17. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer.
Connor JP; Felder M; Hank J; Harter J; Gan J; Gillies SD; Sondel P
J Immunother; 2004; 27(3):211-9. PubMed ID: 15076138
[TBL] [Abstract][Full Text] [Related]
20. May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer?
Kokcu A; Kurtoglu E; Celik H; Tosun M; Malatyalıoglu E; Ozdemir AZ
Asian Pac J Cancer Prev; 2014; 15(22):9781-4. PubMed ID: 25520104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]